sp-102
Lumbosacral Radicular Pain
Semnur Pharmaceuticals, Inc.Phase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Lumbosacral Radicular Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Triamcinalone University of Miami | Phase 4 | BBB |
LIDOCAINE Sheba Medical Center | Phase 4 | BBB |
DEXAMETHASONE Semnur Pharmaceuticals, Inc. | Phase 4 | BB |
Celestone Sheba Medical Center | Phase 4 | BB |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Express Specialty Pharmacy | Phase 3 | BB |
View all 37 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →